Epistaxis Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026

  • Published : Dec-2017
  • Tables : 131
  • Figures : 81
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT344MR
  • Format : ppt

Conditions that predispose a person to nosebleeds include dry and less humid weather conditions and increasing prevalence of hypertension. According to World Health Organization (WHO), over 12% of the deaths caused globally are due to hypertension. Incidence of nosebleeds continue to increase with the increasing cases of hypertension. Moreover, prevalence of hypertension in pregnant women leads to increasing blood flow towards the mucous membrane. Such factors continue to rev up demand for the epistaxis products in the global market.

epistaxis market

According to Fact.MR, the global epistaxis market is expected to represent a value of nearly US$ 13 Mn by the end of 2026.

Market Taxonomy

Region

Product

Distribution Channel

Indication

North America

Vasoconstrictors

Hospitals

Posterior Epistaxis

Latin America

Anesthetics

Specialty Clinics

Anterior Epistaxis

Europe

Antibiotic Ointments

Retail Pharmacies

 

Japan

Cauterizing Agents

Other Distribution Channels

 

APEJ

     

MEA

     

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Extreme Weather Conditions to Impact Global Market Growth

Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to crusting of the mucous secretion processes, which can result into cracks in the nose lining. Extreme dryness and heat in the air can result in dry nasal membrane and eliminates the amount of moisture required to be maintained in the nose. Frequent changes in the environmental conditions such as less humid weather and extremely cold winters lead to increasing instances of dry nasal membrane. Dry nasal membrane leads to increasing occurrences of nosebleeds during the hot, cold and dry weather. Increasing incidences of dry nasal membrane and abnormal nosebleeds is expected to boost demand for epistaxis products during the forecast period. 

Innovative Surgeries to Underscore Lucrative Growth Opportunities

Manufacturers are focusing on developing epistaxis products that offer improved performance and result. Incorporation of innovation in the epistaxis products has led to more effective and advanced treatment procedures for epistaxis. Innovative treatment procedures include various surgical and non-surgical interventional procedure. Innovative treatment for nasal packing, embolization and warm water irrigation are a few non-interventional surgeries.

Endoscopic litigation of sphenopaletine artery, maxillary, artery litigation and nasal cauterization are the innovative treatments that include surgical intervention. Adoption of innovative surgeries are significantly changing the trends in the global epistaxis market. Moreover, manufacturers are increasingly focusing on developing epistaxis products for the treatment of patients with special medical conditions such as asthma, pregnancy, diabetes and cancer. These factors are expected to contribute towards growth of the global epistaxis market during the forecast period.

Anterior Indication to Represent a Leading Segment

With the growing incidences of nose cauterization among the children and adults has led to surge in demand for cauterization agents in the global market. On the basis of product type, the cauterization agents segment is expected to represent the highest revenue growth, accounting for a value of over US$ 30 Mn by the end of 2026. On the other hand, the antibiotic ointment product type segment is expected to register a significant CAGR during the forecast period.

Based on distribution channel, the retail pharmacies segment is expected to generate significant revenues, accounting for a value of nearly US$ 20 Mn by the end of 2017. However, the specialty clinics distribution channel segment is expected to register a robust CAGR through 2026.

By indication, the anterior segment is expected to represent a robust revenue growth, recording a value of nearly US$ 80 Mn by the end of 2026. In contrary, the posterior indication segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating on the global epistaxis market include Bristol-Myers Squibb Company, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Pfizer Inc., Medline Industries, Inc., Smith & Nephew, GlaxoSmithKline PLC and Ferring B.V.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Chapter 1 Global Outlook

Chapter 2 Global Epistaxis Market - Executive Summary

Chapter 3 Global Epistaxis Market Overview
3.1 Introduction
      3.1.1 Global Epistaxis Market Taxonomy
      3.1.2 Global Epistaxis Market Definition
3.2 Global Epistaxis Market Size (US$ Mn) and Forecast, 2012-2026
      3.2.1 Global Epistaxis Market Y-o-Y Growth
3.3 Global Epistaxis Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Epistaxis Epidemiology
3.7 Key Regulations
3.8 Patent Analysis
3.9 PESTL Analysis
3.10 Product Lifecycle
3.11 Pricing Analysis
3.12 Service Provider List
3.13 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Epistaxis Market Analysis and Forecast 2012-2026
4.1 Global Epistaxis Market Size and Forecast by Product, 2012-2026
      4.1.1 Vasoconstrictors Market Size and Forecast, 2012-2026
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region
              4.1.1.2 Market Share Comparison, By Region
              4.1.1.3 Y-o-Y growth Comparison, By Region
      4.1.2 Anesthetics Market Size and Forecast, 2012-2026
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region
              4.1.2.2 Market Share Comparison, By Region
              4.1.2.3 Y-o-Y growth Comparison, By Region
      4.1.3 Antibiotic Ointments Market Size and Forecast, 2012-2026
              4.1.3.1 Revenue (US$ Mn) Comparison, By Region
              4.1.3.2 Market Share Comparison, By Region
              4.1.3.3 Y-o-Y growth Comparison, By Region
      4.1.4 Cauterizing Agents Market Size and Forecast, 2012-2026
              4.1.4.1 Revenue (US$ Mn) Comparison, By Region
              4.1.4.2 Market Share Comparison, By Region
              4.1.4.3 Y-o-Y growth Comparison, By Region
4.2 Global Epistaxis Market Size and Forecast by Distribution Channel, 2012-2026
      4.2.1 Hospitals Market Size and Forecast, 2012-2026
              4.2.1.1 Revenue (US$ Mn) Comparison, By Region
              4.2.1.2 Market Share Comparison, By Region
              4.2.1.3 Y-o-Y growth Comparison, By Region
      4.2.2 Specialty Clinics Market Size and Forecast, 2012-2026
              4.2.2.1 Revenue (US$ Mn) Comparison, By Region
              4.2.2.2 Market Share Comparison, By Region
              4.2.2.3 Y-o-Y growth Comparison, By Region
      4.2.3 Retail Pharmacies Market Size and Forecast, 2012-2026
              4.2.3.1 Revenue (US$ Mn) Comparison, By Region
              4.2.3.2 Market Share Comparison, By Region
              4.2.3.3 Y-o-Y growth Comparison, By Region
      4.2.4 Other Distribution Channels Market Size and Forecast, 2012-2026
              4.2.4.1 Revenue (US$ Mn) Comparison, By Region
              4.2.4.2 Market Share Comparison, By Region
              4.2.4.3 Y-o-Y growth Comparison, By Region
4.3 Global Epistaxis Market Size and Forecast by Indication, 2012-2026
      4.3.1 Posterior Epistaxis Market Size and Forecast, 2012-2026
              4.3.1.1 Revenue (US$ Mn) Comparison, By Region
              4.3.1.2 Market Share Comparison, By Region
              4.3.1.3 Y-o-Y growth Comparison, By Region
      4.3.2 Anterior Epistaxis Market Size and Forecast, 2012-2026
              4.3.2.1 Revenue (US$ Mn) Comparison, By Region
              4.3.2.2 Market Share Comparison, By Region
              4.3.2.3 Y-o-Y growth Comparison, By Region

Chapter 5 North America Epistaxis Market Size and Forecast, 2012-2026
5.1 Region Outlook
      5.1.1 Political Outlook
      5.1.2 Economic Outlook
      5.1.3 Business Environment Outlook
      5.1.4 North America Healthcare Sector Outlook
      5.1.5 Epistaxis Market: North America Region Analysis
5.2 Revenue (US$ Mn) Comparison, By Country
5.3 Revenue (US$ Mn) Comparison, By Product
5.4 Revenue (US$ Mn) Comparison, By Distribution Channel
5.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 6 Latin America Epistaxis Market Size and Forecast, 2012-2026
6.1 Region Outlook
      6.1.1 Political Outlook
      6.1.2 Economic Outlook
      6.1.3 Business Environment Outlook
      6.1.4 Latin America Healthcare Sector Outlook
      6.1.5 Epistaxis Market: Latin America Region Analysis
6.2 Revenue (US$ Mn) Comparison, By Country
6.3 Revenue (US$ Mn) Comparison, By Product
6.4 Revenue (US$ Mn) Comparison, By Distribution Channel
6.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 7 Europe Epistaxis Market Size and Forecast, 2012-2026
7.1 Region Outlook
      7.1.1 Political Outlook
      7.1.2 Economic Outlook
      7.1.3 Business Environment Outlook
      7.1.4 Europe Healthcare Sector Outlook
      7.1.5 Epistaxis Treatment Market: Europe Region Analysis
7.2 Revenue (US$ Mn) Comparison, By Country
7.3 Revenue (US$ Mn) Comparison, By Product
7.4 Revenue (US$ Mn) Comparison, By Distribution Channel
7.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 8 Japan Epistaxis Market Size and Forecast, 2012-2026
8.1 Region Outlook
      8.1.1 Political Outlook
      8.1.2 Economic Outlook
      8.1.3 Business Environment Outlook
      8.1.4 Japan Healthcare Sector Outlook:
      8.1.5 Epistaxis Market: Japan Region Analysis
8.2 Revenue (US$ Mn) Comparison, By Country
8.3 Revenue (US$ Mn) Comparison, By Product
8.4 Revenue (US$ Mn) Comparison, By Distribution Channel
8.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 9 APEJ Epistaxis Market Size and Forecast, 2012-2026
9.1 Region Outlook
      9.1.1 Political Outlook
      9.1.2 Economic Outlook
      9.1.3 Business Environment Outlook
      9.1.4 Asia Pacific Excluding Japan (APEJ) Healthcare Sector Outlook
      9.1.5 Epistaxis Market: APEJ Region Analysis
9.2 Revenue (US$ Mn) Comparison, By Country
9.3 Revenue (US$ Mn) Comparison, By Product
9.4 Revenue (US$ Mn) Comparison, By Distribution Channel
9.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 10 MEA Epistaxis Market Size and Forecast, 2012-2026
10.1 Region Outlook
      10.1.1 Political Outlook
      10.1.2 Economic Outlook
      10.1.3 Business Environment Outlook
      10.1.4 Middle East & Africa (MEA) Healthcare Sector Outlook
      10.1.5 Epistaxis Market: MEA Region Analysis
10.2 Revenue (US$ Mn) Comparison, By Country
10.3 Revenue (US$ Mn) Comparison, By Product
10.4 Revenue (US$ Mn) Comparison, By Distribution Channel
10.5 Revenue (US$ Mn) Comparison, By Indication

Chapter 11 Global Epistaxis Treatment Market – Company Share Analysis, Competitive Landscape and Company Profiles
11.1 Global Epistaxis Treatment Market – Company Share Analysis
11.2 Global Epistaxis Treatment Market – Competitive Landscape
11.3 Global Epistaxis Treatment Market – Company Profiles
      11.3.1 Bristol-Myers Squibb Co.
              11.3.1.1 Company Overview
              11.3.1.2 Product Overview
              11.3.1.3 Key Financials
              11.3.1.4 Key Developments
              11.3.1.5 SWOT Analysis
      11.3.2 Ciron Drugs & Pharmaceuticals Pvt. Ltd.
              11.3.2.1 Company Overview
              11.3.2.2 Product Overview
      11.3.3 Pfizer Inc.
              11.3.3.1 Company Overview
              11.3.3.2 Product Overview
              11.3.3.3 Key Financials
              11.3.3.4 Key Developments
              11.3.3.5 SWOT Analysis
      11.3.4 Medline Industries, Inc
              11.3.4.1 Company Overview
              11.3.4.2 Product Overview
              11.3.4.3 SWOT Analysis
      11.3.5 Smith & Nephew Plc.
              11.3.5.1 Company Overview
              11.3.5.2 Product Overview
              11.3.5.3 Key Financials
              11.3.5.4 SWOT Analysis
      11.3.6 GlaxoSmithKline PLC
              11.3.6.1 Company Overview
              11.3.6.2 Product Overview
              11.3.6.3 Key Financials
              11.3.6.4 Key Developments
              11.3.6.5 SWOT Analysis
      11.3.7 Ferring B.V.
              11.3.7.1 Company Overview
              11.3.7.2 Product Overview
11.4 Key Takeaways

Chapter 12 Fact.MR Research Methodology

Chapter 13 Disclaimer

TABLE 1 Global Epistaxis Market Value (US$ Mn), 2012-2017
TABLE 2 Global Epistaxis Market Value (US$ Mn), 2018-2026
TABLE 3 Global Epistaxis Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Vasoconstrictors Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Vasoconstrictors Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Vasoconstrictors Segment Market Share, By Region 2012-2017
TABLE 7 Global Vasoconstrictors Segment Market Share, By Region 2018-2026
TABLE 8 Global Vasoconstrictors Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Anesthetics Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Anesthetics Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Anesthetics Segment Market Share, By Region 2012-2017
TABLE 12 Global Anesthetics Segment Market Share, By Region 2018-2026
TABLE 13 Global Anesthetics Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Antibiotic Ointments Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Antibiotic Ointments Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Antibiotic Ointments Segment Market Share, By Region 2012-2017
TABLE 17 Global Antibiotic Ointments Segment Market Share, By Region 2018-2026
TABLE 18 Global Antibiotic Ointments Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Cauterizing Agents Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Cauterizing Agents Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Cauterizing Agents Segment Market Share, By Region 2012-2017
TABLE 22 Global Cauterizing Agents Segment Market Share, By Region 2018-2026
TABLE 23 Global Cauterizing Agents Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Hospitals Segment Market Share, By Region 2012-2017
TABLE 27 Global Hospitals Segment Market Share, By Region 2018-2026
TABLE 28 Global Hospitals Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Specialty Clinics Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Specialty Clinics Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Specialty Clinics Segment Market Share, By Region 2012-2017
TABLE 32 Global Specialty Clinics Segment Market Share, By Region 2018-2026
TABLE 33 Global Specialty Clinics Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 37 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 38 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Other Distribution Channels Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Other Distribution Channels Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Other Distribution Channels Segment Market Share, By Region 2012-2017
TABLE 42 Global Other Distribution Channels Segment Market Share, By Region 2018-2026
TABLE 43 Global Other Distribution Channels Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Posterior Epistaxis Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Posterior Epistaxis Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Posterior Epistaxis Segment Market Share, By Region 2012-2017
TABLE 47 Global Posterior Epistaxis Segment Market Share, By Region 2018-2026
TABLE 48 Global Posterior Epistaxis Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Anterior Epistaxis Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Anterior Epistaxis Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Anterior Epistaxis Segment Market Share, By Region 2012-2017
TABLE 52 Global Anterior Epistaxis Segment Market Share, By Region 2018-2026
TABLE 53 Global Anterior Epistaxis Segment Y-o-Y, By Region 2017-2026
TABLE 54 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 55 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 56 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 57 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 58 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 59 North America Epistaxis Market Value (US$ Mn), By Country 2012-2017
TABLE 60 North America Epistaxis Market Value (US$ Mn), By Country 2018-2026
TABLE 61 North America Epistaxis Market Value (US$ Mn), By Product 2012-2017
TABLE 62 North America Epistaxis Market Value (US$ Mn), By Product 2018-2026
TABLE 63 North America Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 64 North America Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 65 North America Epistaxis Market Value (US$ Mn), By Indication 2012-2017
TABLE 66 North America Epistaxis Market Value (US$ Mn), By Indication 2018-2026
TABLE 67 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 68 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 69 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 70 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 71 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 72 Latin America Epistaxis Market Value (US$ Mn), By Country 2012-2017
TABLE 73 Latin America Epistaxis Market Value (US$ Mn), By Country 2018-2026
TABLE 74 Latin America Epistaxis Market Value (US$ Mn), By Product 2012-2017
TABLE 75 Latin America Epistaxis Market Value (US$ Mn), By Product 2018-2026
TABLE 76 Latin America Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 77 Latin America Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 78 Latin America Epistaxis Market Value (US$ Mn), By Indication 2012-2017
TABLE 79 Latin America Epistaxis Market Value (US$ Mn), By Indication 2018-2026
TABLE 80 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 81 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 82 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 83 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 84 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 85 Europe Epistaxis Market Value (US$ Mn), By Country 2012-2017
TABLE 86 Europe Epistaxis Market Value (US$ Mn), By Country 2018-2026
TABLE 87 Europe Epistaxis Market Value (US$ Mn), By Product 2012-2017
TABLE 88 Europe Epistaxis Market Value (US$ Mn), By Product 2018-2026
TABLE 89 Europe Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 90 Europe Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 91 Europe Epistaxis Market Value (US$ Mn), By Indication 2012-2017
TABLE 92 Europe Epistaxis Market Value (US$ Mn), By Indication 2018-2026
TABLE 93 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 94 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 95 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 96 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 97 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 98 Japan Epistaxis Market Value (US$ Mn), By Country 2012-2017
TABLE 99 Japan Epistaxis Market Value (US$ Mn), By Country 2018-2026
TABLE 100 Japan Epistaxis Market Value (US$ Mn), By Product 2012-2017
TABLE 101 Japan Epistaxis Market Value (US$ Mn), By Product 2018-2026
TABLE 102 Japan Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 103 Japan Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 104 Japan Epistaxis Market Value (US$ Mn), By Indication 2012-2017
TABLE 105 Japan Epistaxis Market Value (US$ Mn), By Indication 2018-2026
TABLE 106 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 107 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 108 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 109 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 110 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 111 APEJ Epistaxis Market Value (US$ Mn), By Country 2012-2017
TABLE 112 APEJ Epistaxis Market Value (US$ Mn), By Country 2018-2026
TABLE 113 APEJ Epistaxis Market Value (US$ Mn), By Product 2012-2017
TABLE 114 APEJ Epistaxis Market Value (US$ Mn), By Product 2018-2026
TABLE 115 APEJ Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 116 APEJ Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 117 APEJ Epistaxis Market Value (US$ Mn), By Indication 2012-2017
TABLE 118 APEJ Epistaxis Market Value (US$ Mn), By Indication 2018-2026
TABLE 119 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 120 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 121 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 122 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 123 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 124 MEA Epistaxis Market Value (US$ Mn), By Country 2012-2017
TABLE 125 MEA Epistaxis Market Value (US$ Mn), By Country 2018-2026
TABLE 126 MEA Epistaxis Market Value (US$ Mn), By Product 2012-2017
TABLE 127 MEA Epistaxis Market Value (US$ Mn), By Product 2018-2026
TABLE 128 MEA Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 129 MEA Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 130 MEA Epistaxis Market Value (US$ Mn), By Indication 2012-2017
TABLE 131 MEA Epistaxis Market Value (US$ Mn), By Indication 2018-2026

FIG. 1 Global Epistaxis Market Value (US$ Mn), 2012-2017
FIG. 2 Global Epistaxis Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Epistaxis Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Vasoconstrictors Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Vasoconstrictors Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Vasoconstrictors Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Anesthetics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Anesthetics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Anesthetics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Antibiotic Ointments Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Antibiotic Ointments Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Antibiotic Ointments Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Cauterizing Agents Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Cauterizing Agents Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Cauterizing Agents Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Specialty Clinics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Specialty Clinics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Specialty Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Other Distribution Channels Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Other Distribution Channels Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Other Distribution Channels Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Posterior Epistaxis Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Posterior Epistaxis Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Posterior Epistaxis Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Anterior Epistaxis Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Anterior Epistaxis Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Anterior Epistaxis Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 North America Epistaxis Market Value (US$ Mn), By Country 2012-2017
FIG. 35 North America Epistaxis Market Value (US$ Mn), By Country 2018-2026
FIG. 36 North America Epistaxis Market Value (US$ Mn), By Product 2012-2017
FIG. 37 North America Epistaxis Market Value (US$ Mn), By Product 2018-2026
FIG. 38 North America Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 39 North America Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 40 North America Epistaxis Market Value (US$ Mn), By Indication 2012-2017
FIG. 41 North America Epistaxis Market Value (US$ Mn), By Indication 2018-2026
FIG. 42 Latin America Epistaxis Market Value (US$ Mn), By Country 2012-2017
FIG. 43 Latin America Epistaxis Market Value (US$ Mn), By Country 2018-2026
FIG. 44 Latin America Epistaxis Market Value (US$ Mn), By Product 2012-2017
FIG. 45 Latin America Epistaxis Market Value (US$ Mn), By Product 2018-2026
FIG. 46 Latin America Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 47 Latin America Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 48 Latin America Epistaxis Market Value (US$ Mn), By Indication 2012-2017
FIG. 49 Latin America Epistaxis Market Value (US$ Mn), By Indication 2018-2026
FIG. 50 Europe Epistaxis Market Value (US$ Mn), By Country 2012-2017
FIG. 51 Europe Epistaxis Market Value (US$ Mn), By Country 2018-2026
FIG. 52 Europe Epistaxis Market Value (US$ Mn), By Product 2012-2017
FIG. 53 Europe Epistaxis Market Value (US$ Mn), By Product 2018-2026
FIG. 54 Europe Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 55 Europe Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 56 Europe Epistaxis Market Value (US$ Mn), By Indication 2012-2017
FIG. 57 Europe Epistaxis Market Value (US$ Mn), By Indication 2018-2026
FIG. 58 Japan Epistaxis Market Value (US$ Mn), By Country 2012-2017
FIG. 59 Japan Epistaxis Market Value (US$ Mn), By Country 2018-2026
FIG. 60 Japan Epistaxis Market Value (US$ Mn), By Product 2012-2017
FIG. 61 Japan Epistaxis Market Value (US$ Mn), By Product 2018-2026
FIG. 62 Japan Epistaxis Market Value (US$ Mn), By Indication 2012-2017
FIG. 63 Japan Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 64 Japan Epistaxis Market Value (US$ Mn), By Indication 2012-2017
FIG. 65 Japan Epistaxis Market Value (US$ Mn), By Indication 2018-2026
FIG. 66 APEJ Epistaxis Market Value (US$ Mn), By Country 2012-2017
FIG. 67 APEJ Epistaxis Market Value (US$ Mn), By Country 2018-2026
FIG. 68 APEJ Epistaxis Market Value (US$ Mn), By Product 2012-2017
FIG. 69 APEJ Epistaxis Market Value (US$ Mn), By Product 2018-2026
FIG. 70 APEJ Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 71 APEJ Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 72 APEJ Epistaxis Market Value (US$ Mn), By Indication 2012-2017
FIG. 73 APEJ Epistaxis Market Value (US$ Mn), By Indication 2018-2026
FIG. 74 MEA Epistaxis Market Value (US$ Mn), By Country 2012-2017
FIG. 75 MEA Epistaxis Market Value (US$ Mn), By Country 2018-2026
FIG. 76 MEA Epistaxis Market Value (US$ Mn), By Product 2012-2017
FIG. 77 MEA Epistaxis Market Value (US$ Mn), By Product 2018-2026
FIG. 78 MEA Epistaxis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 79 MEA Epistaxis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 80 MEA Epistaxis Market Value (US$ Mn), By Indication 2012-2017
FIG. 81 MEA Epistaxis Market Value (US$ Mn), By Indication 2018-2026

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development